Health X Platform Ltd — earnings calls
1 quarter summarised from transcripts filed with the exchange, every statement cited. Newest first.
Q1 FY27 — transcript filed; not yet summarisedQ4 FY26
Q4 FY26 earnings call
Health X Platform (formerly Sastasundar Ventures) reported Q4 FY26 revenue of Rs 356 crore, up 22% year-on-year, with EBITDA losses narrowing to Rs 20 crore from Rs 29 crore a year earlier. For the full year, revenue reached Rs 1,283 crore with EBITDA losses reduced to Rs 65 crore and a near breakeven PAT loss of Rs 1.4 crore. Management also discussed the launch of the JITO generic medicine brand, capacity expansion plans, and a proposed demerger of the finance division into a separately listed entity called Microsec Resources.